Letter by Aw et al Regarding Article, “Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention”
Author:
Affiliation:
1. Khoo Teck Puat Hospital, Singapore, Singapore (J.W.X.A., D.S.-Y.T.).
2. Tan Tock Seng Hospital, Singapore, Singapore (L.L.G.).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference5 articles.
1. Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention.;Lee CR;Circ Genom Precis Med,2018
2. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
3. Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary intervention
4. CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel
5. Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI;Journal of Geriatric Cardiology;2024-01
2. Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack;International Journal of Stroke;2023-09-29
3. Role of Cytochrome p450 in Clopidogrel Resistance in Indonesian Stroke Patients;Open Access Macedonian Journal of Medical Sciences;2023-05-23
4. Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack;2023-05-17
5. Impact of Cyp2c19 Allele 17 Mutase on Clopidogrel Hyper-Responsiveness in Indonesian Patients with Ischemic Stroke;Open Access Macedonian Journal of Medical Sciences;2023-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3